Folate receptor-mediated targeting of liposomal drugs to cancer cells.
Stephenson
Stacy M
SM
Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, 43210, USA.
Low
Philip S
PS
Lee
Robert J
RJ
D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001692:Biological Transport; D002352:Carrier Proteins / Q000502:physiology*; D045744:Cell Line, Tumor; D004337:Drug Carriers; D058973:Folate Receptors, GPI-Anchored; D005492:Folic Acid / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism*; D006801:Humans; D007202:Indicators and Reagents; D008081:Liposomes; D016376:Oligonucleotides, Antisense / Q000493:pharmacokinetics; D011092:Polyethylene Glycols; D011956:Receptors, Cell Surface / Q000502:physiology*
D000970:Antineoplastic Agents; D002352:Carrier Proteins; D004337:Drug Carriers; D058973:Folate Receptors, GPI-Anchored; D007202:Indicators and Reagents; D008081:Liposomes; D016376:Oligonucleotides, Antisense; D011956:Receptors, Cell Surface; D011092:Polyethylene Glycols; D005492:Folic Acid